KIT and gastrointestinal stromal tumor: To confirm such observation, we examined the distribution of KIT in GIST48 and GIST430, the two IM-resistant cell lines whose secondary KIT mutation in exon 17D820A and exon 13V654A, respectively, are responsible for acquired resistance in >50% of IM-resistant cases of GIST.